Ars Pharmaceuticals Inc (SPRY)

Investing Cash Flow

$48.50M

TTM · Period ending: · USD

SPRY logo

SPRY Investing Cash Flow

Latest reported$48.50M
SPRY TTM Cash from Investing (-$773.00K → $48.50M)
High-resolution chart · PNG

SPRY investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ars Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
48,496,000
55,495,000
56,768,000
-69,106,000
-7,307,000
-68,524,000
-106,101,000
21,698,000
-41,763,000
15,853,000
-87,180,000
-113,345,000
-66,732,000
-111,724,000
-199,000
-25,758,000
-65,786,000
-66,464,000
-66,478,000
-40,798,000
-773,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.